24.2 C
New York
Thursday, June 11, 2026

Tag: transfer

Graphjet Board of Directors Determines Effective Date for Share Consolidation

New York, United States, Aug. 15, 2025 (GLOBE NEWSWIRE) --  Graphjet Technology (NADSAQ: GTI) (the “Company”) today announced that its board of directors (the “Board”) has determined the effective date for the previously approved share consolidation of the Company’s ordinary shares at a ratio of 1-for-60  and to reduce the par value of the Company’s ordinary shares from $0.0001 per share to $0.006 per share (the “Share Consolidation”).

Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years

Brooge Energy Limited Sets Record Date – Holders urged to contact brokers to register shares with Continental Stock Transfer & Trust if they are...

DUBAI, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Brooge Energy Limited, a Cayman Islands-based infrastructure provider, which is engaged in Clean Petroleum Products and Biofuels and Crude Oil storage and related services, is pleased to report that its Transaction with GulfNav, as described in its press release dated May 27, 2025, is proceeding according to plan.  While the Transaction remains subject to conditions and a completion date has not yet been determined, the Company’s expects the closing to occur during the fourth quarter of 2025.

LanzaTech Announces Reverse Stock Split as Part of Nasdaq Compliance Plan

CHICAGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (“LanzaTech” or the “Company”) (NASDAQ: LNZA), a leading carbon capture and transformation company, today announced that it will implement a 1-for-100 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding common stock (the “Common Stock”), effective August 18, 2025 at 5:00 p.m. Eastern Time. Immediately prior to effecting the Reverse Stock Split, LanzaTech will decrease the par value of the Common Stock from $0.0001 to $0.0000001 per share (the “Par Value Change”) and increase the number of authorized shares of Common Stock from 600,000,000 to 2,580,000,000 (the “Authorized Share Increase”). At the effective time of the Reverse Stock Split, the number of authorized shares of Common Stock will be proportionately decreased to 25,800,000. The Reverse Stock Split, Par Value Change, and Authorized Share Increase were approved by stockholders at LanzaTech's 2025 Annual Meeting of Stockholders held on July 28, 2025.

Leading the future with AI & mobility: NetDragon’s Cherrypicks & Zhongke WengAI’s Strategic Alliance

Wenge Invests in Cherrypicks to Jointly Drive China's AI Go-Global Strategy and Elevate Hong Kong's AI Ecosystem HONG KONG, Aug. 15, 2025 /PRNewswire/ -- NetDragon...

Leading the future with AI & mobility: NetDragon’s Cherrypicks & Zhongke WengAI’s Strategic Alliance

Wenge Invests in Cherrypicks to Jointly Drive China's AI Go-Global Strategy and Elevate Hong Kong's AI Ecosystem HONG KONG, Aug. 15, 2025 /PRNewswire/ -- NetDragon...

XCMG Delivers Batch of Compact Hydrostatic Loaders to the European Market

KREFELD, Germany, Aug. 15, 2025 /PRNewswire/ -- XCMG Machinery (SHE:000425) has recently shipped off a fleet of XC908HST compact hydrostatic wheel loaders to Hamburg...

Sahm Capital Signs Strategic Agreement with WalaOne to Empower WalaOne Clients with Investment Services

Bridging digital rewards with capital market access for smarter financial growth.

Realty Income Announces 662nd Consecutive Common Stock Monthly Dividend

SAN DIEGO, Aug. 14, 2025 /PRNewswire/ -- Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company®, today announced that it has declared...

As Agentic AI Gains Traction, 86% of Enterprises Anticipate Heightened Risks, Yet Only 2% of Companies Meet Responsible AI Gold Standards

With 95% of enterprises facing incidents, Infosys research reveals wide gap between AI adoption and responsible AI readiness, exposing most enterprises to reputational risks...

FRONTERA ANNOUNCES SECOND QUARTER 2025 RESULTS

Recorded $455.2 million in Net Loss Mainly due to Non-Cash Impairment Charges Related to its Interest in the Corentyne License and Ecuadorian Assets Increased Total...

FRONTERA ANNOUNCES SECOND QUARTER 2025 RESULTS

Recorded $455.2 million in Net Loss Mainly due to Non-Cash Impairment Charges Related to its Interest in the Corentyne License and Ecuadorian Assets Increased Total...

Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update.

- A word from our sponsors -

spot_img
HomeTagsTransfer